NETTUNIT - Italy-Tunisia Cross-border Environmental network_2

Risk Perception Clinical Trial

Official title:

NETTUNIT - Italy-Tunisia Cross-border Environmental network_2

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05186896
• Other study ID #: 03/2021_2
• Status: Recruiting
• Start date: June 1, 2021
• Est. completion date: March 3, 2023

Study information

• Verified date: December 2021
• Source: Istituto per la Ricerca e l'Innovazione Biomedica
• Contact: Stefania La Grutta, MD
• Phone: 0916809194
• Email: stefania.lagrutta[@]irib.cnr.it
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study involves the development and validation of a questionnaire for risk perception to be administered to residents of areas declared to be at high risk of environmental crisis in the areas of Caltanissetta (Italy) and Tunis (Tunisia). The questionnaire will be administered twice, at baseline and after 1 month.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: March 3, 2023
• Est. primary completion date: March 3, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 90 Years

Eligibility

Inclusion Criteria:

• Individuals aged 20-90 years of both sex, living in the areas of Caltanissetta (Italy) and Tunis (Tunisia).

Exclusion Criteria:

• Individuals with learning difficulties.

Related Conditions & MeSH terms

• Risk Perception

Intervention

Other:
• Risk perception questionnaire
A questionnaire for risk perception will be developed and administered

Locations

Country	Name	City	State
Italy	Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)	Palermo

Sponsors (1)

Lead Sponsor	Collaborator
Istituto per la Ricerca e l'Innovazione Biomedica

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Construct validity of the questionnaire score at baseline administration	The ability of the questionnaire score at baseline to differentiate between sub-samples that are known or expected to differ	Baseline administration
Primary	Construct validity of the questionnaire score 1 month after the baseline administration	The ability of the questionnaire score 1 month after the baseline administration to differentiate between sub-samples that are known or expected to differ	1 month after the baseline administration
Primary	Repeatability of the questionnaire score between the first (baseline) and second (1 month) administration	The extent to which the answer distribution will be similar between the two administrations	Baseline administration and 1 month after the baseline administration